This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Chdi Foundation, Inc.. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Cole Clissold: Innovator in ATM Kinase Inhibitors
Introduction
Cole Clissold is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of biotechnology, particularly in the development of ATM kinase inhibitors. His work is essential for advancing therapeutic methods and compositions that can impact various medical conditions.
Latest Patents
Cole Clissold holds a patent for "ATM kinase inhibitors and compositions and methods of use thereof." This patent includes specific ATM kinase inhibitors of Formula I, along with compositions of such compounds and methods for their use. His innovative approach in this area has the potential to lead to new treatments and therapies.
Career Highlights
Cole Clissold is currently associated with the Chdi Foundation, Inc., where he continues to work on groundbreaking research. His expertise in kinase inhibitors positions him as a valuable asset in the field of medical research and development.
Collaborations
Cole collaborates with talented individuals such as Leticia M Toledo-Sherman and Celia Dominguez. Their combined efforts contribute to the advancement of research in their respective fields.
Conclusion
Cole Clissold's work in ATM kinase inhibitors exemplifies the innovative spirit of modern inventors. His contributions are paving the way for future advancements in medical therapies.